Novartis
Company Growth (employees)
Novartis was founded in 1996 and is headquartered in Basel, CH
Key People at Novartis
Joseph Jimenez
Chief Executive Officer
Harry Kirsch
Chief Financial Officer
Paul van Arkel
Head of Corporate Strategy and Healthcare Systems
Peter Elam
Head of Internal Audit
Erwin Vanhaecke
Head Novartis Group Quality
Michael Willi
Group Head of Communications
Felix Ehrat
Group General Counsel
Richard Francis
CEO, Sandoz
Andre Wyss
President, Novartis Operations Country President for Switzerland
Juergen Brokatzky-Geiger
Global Head, Corporate Responsibility for Novartis
Michael Ball
CEO, Alcon
James Bradner
President, Novartis Institutes for BioMedical Research
Paul Hudson
CEO, Novartis Pharmaceuticals
Bruno Strigini
CEO, Novartis Oncology
Steven Baert
Head of Human Resources
Novartis Office Locations
Novartis has offices in Basel, East Hanover, New York, Wehr and in 2 other locations
Basel, CH (HQ)
Forum 1, Novartis Campus
Tokyo, JP
Toranomon Hills, Mori Tower, 1 23 1, Toranomon, Minato Ku
Beijing, CN
14th Floor, China World Tower 2, No.1 Jian Guo Men Wai Avenue, Chao Yang District
Wehr, DE
Oeflingerstrasse 44
New York, US
230 Park Avenue, 21st Floor
East Hanover, US
1 Health Plazam, Bldg. 101
Novartis Data and Metrics
Novartis Financial Metrics
Novartis's revenue was reported to be $48.5 b in FY, 2016 which is a 2% decrease from the previous period.
USD
Revenue (FY, 2016) | 48.5 b |
Revenue growth (FY, 2015 - FY, 2016), % | (2%) |
Gross profit (FY, 2016) | 31 b |
Gross profit margin (FY, 2016), % | 64% |
Net income (FY, 2016) | 6.7 b |
Market capitalization (31-Jan-2017) | 175.5 b |
Closing share price (31-Jan-2017) | 72.3 |
Novartis's current market capitalization is $175.5 b.
- Source: Company Filings
| USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Revenue | 53.6 b | 49.4 b | 48.5 b |
Revenue growth, % | (8%) | (2%) | |
Cost of goods sold | 17.3 b | 17.4 b | 17.5 b |
Gross profit | 36.3 b | 32 b | 31 b |
Gross profit Margin, % | 68% | 65% | 64% |
Sales and marketing expense | 12.4 b | 11.8 b | 12 b |
R&D expense | 9.1 b | 8.9 b | 9 b |
General and administrative expense | 2.6 b | 2.5 b | 2.2 b |
Operating expense total | 25.2 b | 24 b | 23.6 b |
Interest expense | (704 m) | (655 m) | (707 m) |
Interest income | (31 m) | (454 m) | (447 m) |
Net Income | 10.3 b | 17.8 b | 6.7 b |
- Source: Company Filings
| USD | FY, 2015 | FY, 2016 |
|---|---|---|
Cash From Operating Activities | 12.1 b | 11.5 b |
| USD | Y, 2016 |
|---|---|
Revenue/Employee | 411.2 k |
Novartis Market Value History
Novartis Revenue Breakdown
Novartis Job Categories
Novartis Median Salaries
Source: 453 public H-1B filings from Novartis
